Hi! Simply click below and type your query.
Our experts will reply you very soon.
|Molar Mass||464.825 g/mol|
|Click to view more|
Preferred Buyer From
|Location||All Countries Except India|
Sorafenib, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.